DigestRedComo funciona
Red
/
Empresas
SO
No verificado

SOTIO Biotech

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaOncologíaSalud

12 Comunicados de prensa

Ver todos los comunicados de prensa
12/11/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Finanzas
Industria
Eventos
SOTIO Presents Positive Results from Non-Human Primate Study of SOT106, a Potential Best-in-Class ADC for Treatment of Sarcoma
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
03/11/2025
Biotecnología
Farmacéutica
Salud
Oncología
Mercado laboral
SOTIO Announces Promotion of Vivi Boura to Chief Medical Officer
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
30/10/2025
Eventos
Industria
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
SOTIO to Present Data Highlighting Progress Across ADC and Immunocytokine Programs at Upcoming Scientific Conferences
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
02/10/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
SOTIO Strengthens Leadership Team with Appointments of Amy Jensen-Smith as Chief Scientific Officer and Ulrich Moebius as Chief Development Officer
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
29/04/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
SOTIO Reports Promising Preclinical Data on Antibody-Drug Conjugates SOT109 and SOT106, Underscoring Best-in-Class Potential for Solid Tumor Treatments
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
26/03/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
SOTIO to Present Preclinical Data on Lead Antibody-Drug Conjugates, SOT106 and SOT109, at 2025 AACR Annual Meeting
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
13/03/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Sanidad
Salud
SOTIO Expands ADC Pipeline and Synaffix Collaboration to Develop Two Novel Bispecific Candidates, SOT112 and SOT113
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
03/03/2025
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Ciencia
Medicina - Varios
Eventos
Industria
SOTIO Unveils Promising Preclinical Data on SOT109, a Next-Gen ADC Targeting Cadherin-17 (CDH17) for Colorectal Cancer
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
09/01/2025
Mercado laboral
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Medicina - Varios
SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumor Target
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
SOTIO Showcases New Data on SOT201 Immunocytokine, VICTORIA-01 Clinical Study, and BOXR CAR-T Advancements at 2024 SITC Annual Meeting
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0